{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:58:32Z","timestamp":1763755112442,"version":"3.45.0"},"reference-count":26,"publisher":"Oncology Nursing Society (ONS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2007,8,1]]},"DOI":"10.1188\/07.cjon.553-559","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T10:53:33Z","timestamp":1188471213000},"page":"553-559","source":"Crossref","is-referenced-by-count":5,"title":["Intravesical Antineoplastic Therapy Following Transurethral Resection of Bladder Tumors: Nursing Implications From the Operating Room to Discharge"],"prefix":"10.1188","volume":"11","author":[{"given":"Donna J.","family":"Washburn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2007,8,27]]},"reference":[{"key":"1","unstructured":"Agency for Healthcare Research and Quality. (2005). <i>The guide to clinical preventive services 2005.<\/i> Rockville, MD: Author."},{"key":"2","unstructured":"American Cancer Society. (2006). Detailed guide: Bladder cancer. Retrieved June 16, 2006, from <a target=\"_blank\" href='http:\/\/www.cancer.org\/docroot\/CRI\/CRI_2_3x.asp?dt=44'>http:\/\/www.cancer.org\/docroot\/CRI\/CRI_2_3x.asp?dt=44<\/a>"},{"key":"3","unstructured":"American Urological Association. (1999). <i>Report on the management of non-muscle-invasive bladder cancer (stages Ta, T1 and Tis).<\/i> Baltimore: Author."},{"key":"4","unstructured":"American Urological Association. (2003). Bladder cancer. Retrieved April 1, 2006, from <a target=\"_blank\" href='http:\/\/www.urologyhealth.org\/print\/index.cfm?topic=37'>http:\/\/www.urologyhealth.org\/print\/index.cfm?topic=37<\/a>"},{"key":"5","first-page":"189","article-title":"Intravesical bacillus calmette-guerin for treating bladder cancer","volume":"23","author":"L. Boyd","year":"2003","journal-title":"Urologic Nursing"},{"issue":"4","key":"6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00152193-200604000-00041","article-title":"Bladder cancer: Revealing news about a hidden threat","volume":"36","author":"B. Campbell","year":"2006","journal-title":"Nursing"},{"key":"7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"A. Jemal","year":"2007","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"8","unstructured":"Johns Hopkins University. (2006). <i>Bladder cancer.<\/i> Retrieved June 16, 2006, from <a target=\"_blank\" href='http:\/\/pathology2.jhu.edu\/bladdercancer\/'>http:\/\/pathology2.jhu.edu\/bladdercancer\/<\/a>"},{"key":"9","first-page":"323","article-title":"Bladder cancer: Current optimal intravesical treatment","volume":"25","author":"D. Lamm","year":"2005","journal-title":"Urologic Nursing"},{"first-page":"24","volume-title":"Pharmacology for nursing care","year":"2004","key":"10"},{"key":"11","first-page":"1800","volume-title":"Clinical oncology","author":"J. Montie","year":"2004"},{"key":"12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1464-410X.2006.05965.x","article-title":"Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer","volume":"97","author":"A. Mostafid","year":"2006","journal-title":"BJU International"},{"key":"13","unstructured":"National Comprehensive Cancer Network. (2007). NCCN clinical practice guidelines in oncology. Bladder cancer: Including upper tract tumors and urothelial carcinoma of the prostate v.1.2007. Retrieved July 17, 2007, from <a target=\"_blank\" href='http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/bladder.pdf'>http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/bladder.pdf<\/a>"},{"key":"14","unstructured":"National Institute for Occupational Safety and Health. (2004). <i>Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings.<\/i> Cincinnati, OH: Author."},{"key":"15","unstructured":"National Institutes of Health. (2007). Clinical trials.gov. Retrieved July 17, 2007, from <a target=\"_blank\" href='http:\/\/clinicaltrials.gov\/ct\/screen\/BrowseAny?path=%2Fbrowse%2Fby-condition%2Faz%2FB%2FD001749%2BBladder%2BNeoplasms&recruiting=true'>http:\/\/clinicaltrials.gov\/ct\/screen\/BrowseAny?path=%2Fbrowse%2Fby-condition%2Faz%2FB%2FD001749%2BBladder%2BNeoplasms&recruiting=true<\/a>"},{"key":"16","unstructured":"National Library of Medicine. (2006). Home urine testing cuts bladder cancer deaths. Retrieved June 20, 2006, from <a target=\"_blank\" href='http:\/\/www.nlm.nih.gov\/medlineplus\/news\/fullstory_34070.html'>http:\/\/www.nlm.nih.gov\/medlineplus\/news\/fullstory_34070.html<\/a>"},{"key":"17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0302-2838(03)00151-9","article-title":"Unusual complication after immediate postoperative intravesical mitomycin C instillation","volume":"43","author":"J. Nieuwenhuijzen","year":"2003","journal-title":"European Urology"},{"key":"18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)54642-X","article-title":"Side effects associated with intravesical mitomycin","volume":"126","author":"I. Nissenkorn","year":"1981","journal-title":"Journal of Urology"},{"key":"19","first-page":"213","volume-title":"Oncology nursing","author":"M. O'Rourke","year":"2001"},{"volume-title":"Safe handling of hazardous drugs","year":"2003","author":"M. Polovich","key":"20"},{"volume-title":"Chemotherapy and biotherapy guidelines and recommendations for practice","year":"2005","key":"21"},{"key":"22","unstructured":"Sanofi Pasteur Limited. (2006). BCG live (Intravesical): TheraCys\u00ae [Package insert]. Toronto, Canada: Author."},{"volume-title":"PDR nurse's drug handbook: The information standard for prescription drugs and nursing considerations","year":"2005","author":"G. Spratto","key":"23"},{"key":"24","first-page":"136","article-title":"Nursing care of the patient receiving intravesical chemotherapy","volume":"12","author":"D. Switters","year":"1992","journal-title":"Urologic Nursing"},{"volume-title":"Smith's general urology","year":"2004","author":"E. Tanagho","key":"25"},{"key":"26","unstructured":"U.S. Food and Drug Administration & Center for Drug Evaluation and Research. (2001). FDA oncology tools product label details for administration of thiotepa. Retrieved February 21, 2006, from <a target=\"_blank\" href='http:\/\/www.accessdata.fda.gov\/scripts\/cder\/onctools\/administer.cfm?GN=thiotepa'>http:\/\/www.accessdata.fda.gov\/scripts\/cder\/onctools\/administer.cfm?GN=thiotepa<\/a>"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/AQK68734K5VU5642.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:07Z","timestamp":1763754667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/11\/4\/intravesical-antineoplastic-therapy-following-transurethral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8,1]]}},"alternative-id":["AQK68734K5VU5642"],"URL":"https:\/\/doi.org\/10.1188\/07.cjon.553-559","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}